CD40LG and COVID-19: The IgG results demonstrated a high PPA of the PanbioTM COVID-19 IgG/IgM test in comparison with the ArchitectTM SARS-CoV-2 IgG test, when used with fingerstick and venous whole blood and with plasma; the NPA was lower.